First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817
==============================================================================================================================================================================

* Neal E Ready
* Clarisse Audigier-Valette
* Jonathan W Goldman
* Enriqueta Felip
* Tudor-Eliade Ciuleanu
* María Rosario García Campelo
* Kevin Jao
* Fabrice Barlesi
* Stéphanie Bordenave
* Erika Rijavec
* Laszlo Urban
* Jean-Sébastien Aucoin
* Cristina Zannori
* Karim Vermaelen
* Osvaldo Arén Frontera
* Alessandra Curioni Fontecedro
* Amparo Sánchez-Gastaldo
* Oscar Juan-Vidal
* Helena Linardou
* Elena Poddubskaya
* David R Spigel
* Samreen Ahmed
* Michele Maio
* Sunney Li
* Han Chang
* Joseph Fiore
* Angelic Acevedo
* Luis Paz-Ares